Cargando…

Protective Effects of Costunolide Against D-Galactosamine and Lipopolysaccharide-Induced Acute Liver Injury in Mice

Costunolide, a sesquiterpene isolated from Vladimiria souliei (Franch.) Ling, is known to exhibit anti-inflammatory, anti-viral, and anti-tumor activities. However, the effects of costunolide on liver injury are poorly understood. The current study aimed to investigate the hepatoprotective effects o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Jingxin, Yi, Man, Wang, Rui, Huang, Yuanshe, Chen, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307542/ https://www.ncbi.nlm.nih.gov/pubmed/30618760 http://dx.doi.org/10.3389/fphar.2018.01469

Ejemplares similares

The Protection of Midazolam Against Immune Mediated Liver Injury Induced by Lipopolysaccharide and Galactosamine in Mice
por: Li, Jian, et al.
Publicado: (2019)

Protective Role of Mytilus edulis Hydrolysate in Lipopolysaccharide-Galactosamine Acute Liver Injury
por: Starikova, Eleonora, et al.
Publicado: (2021)

Deficiency of interleukin-19 exacerbates lipopolysaccharide/D-galactosamine-induced acute liver failure
por: FUJIMOTO, Yasuyuki, et al.
Publicado: (2020)

The Protective Effect of Cordycepin on D-Galactosamine/Lipopolysaccharide-Induced Acute Liver Injury
por: Li, Jin, et al.
Publicado: (2017)

Interleukin-35 Attenuates D-Galactosamine/Lipopolysaccharide-Induced Liver Injury via Enhancing Interleukin-10 Production in Kupffer Cells
por: Zheng, Xing-Feng, et al.
Publicado: (2018)

Catalpol protects mice against Lipopolysaccharide/D-galactosamine-induced acute liver injury through inhibiting inflammatory and oxidative response
por: Zhang, Haogang, et al.
Publicado: (2017)

The Protective Role of Pregnane X Receptor in Lipopolysaccharide/D-galactosamine-induced Acute Liver Injury
por: Wang, Kun, et al.
Publicado: (2009)

Protective Effect of Luteolin on D-Galactosamine (D-Gal)/Lipopolysaccharide (LPS) Induced Hepatic Injury by in Mice
por: Pu, Yiwei, et al.
Publicado: (2021)

Protective Role of Shiitake Mushroom-Derived Exosome-Like Nanoparticles in D-Galactosamine and Lipopolysaccharide-Induced Acute Liver Injury in Mice
por: Liu, Baolong, et al.
Publicado: (2020)

Carfilzomib Mitigates Lipopolysaccharide/D-Galactosamine/Dimethylsulfoxide-Induced Acute Liver Failure in Mice
por: Alhareth, Dhafer Y., et al.
Publicado: (2023)

Protective Effect of Danhong Injection on Acute Hepatic Failure Induced by Lipopolysaccharide and D-Galactosamine in Mice
por: Wang, Ying, et al.
Publicado: (2014)

Gasdermin D Inhibitor Necrosulfonamide Alleviates Lipopolysaccharide/D-galactosamine-induced Acute Liver Failure in Mice
por: Wu, Yi-Long, et al.
Publicado: (2022)

Nrf2 signaling and autophagy are complementary in protecting lipopolysaccharide/d-galactosamine-induced acute liver injury by licochalcone A
por: Lv, Hongming, et al.
Publicado: (2019)

Shikonin protects against D-Galactosamine and lipopolysaccharide-induced acute hepatic injury by inhibiting TLR4 signaling pathway
por: Lin, Meng-Xiang, et al.
Publicado: (2017)

Alleviation of lipopolysaccharide/d-galactosamine-induced liver injury in leukocyte cell-derived chemotaxin 2 deficient mice
por: Okumura, Akinori, et al.
Publicado: (2017)

Guanabenz Prevents d-Galactosamine/Lipopolysaccharide-Induced Liver Damage and Mortality
por: Perego, Jessica, et al.
Publicado: (2017)

Co-administration of lipopolysaccharide and d-galactosamine induces genotoxicity in mouse liver
por: Dong, Wenjing, et al.
Publicado: (2021)

Chicoric acid ameliorate inflammation and oxidative stress in Lipopolysaccharide and d‐galactosamine induced acute liver injury
por: Li, Zheng, et al.
Publicado: (2020)

Protective effect of ultrasonication-processed ginseng berry extract on the D-galactosamine/lipopolysaccharide-induced liver injury model in rats
por: Nam, Yoonjin, et al.
Publicado: (2018)

Hepatoprotective Effects of Albumin-Encapsulated Nanoparticles of a Curcumin Derivative COP-22 against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Injury in Mice
por: Mu, Wenwen, et al.
Publicado: (2022)

Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway
por: Pan, Chen-wei, et al.
Publicado: (2017)

Spred2 Deficiency Exacerbates D-Galactosamine/Lipopolysaccharide -induced Acute Liver Injury in Mice via Increased Production of TNFα
por: Yang, Xu, et al.
Publicado: (2018)

Nature and mechanisms of hepatocyte apoptosis induced by d-galactosamine/lipopolysaccharide challenge in mice
por: WU, YI-HANG, et al.
Publicado: (2014)

Adenosine 5′-monophosphate ameliorates D-galactosamine/lipopolysaccharide-induced liver injury through an adenosine receptor-independent mechanism in mice
por: Zhan, Y, et al.
Publicado: (2014)

Integrated Analysis of Gut Microbiome and Liver Metabolome to Evaluate the Effects of Fecal Microbiota Transplantation on Lipopolysaccharide/D-galactosamine-Induced Acute Liver Injury in Mice
por: Yuan, Chunchun, et al.
Publicado: (2023)

Metabonomic analysis of liver tissue from BALB/c mice with d-galactosamine/lipopolysaccharide-induced acute hepatic failure
por: Feng, Bo, et al.
Publicado: (2013)

Esculetin Alleviates Acute Liver Failure following Lipopolysaccharide/D-Galactosamine in Male C57BL/6 Mice
por: Mohamadi-Zarch, Seyed-Mahdi, et al.
Publicado: (2021)

Protective Effects of Lentinan Against Lipopolysaccharide-Induced Mastitis in Mice
por: Yin, Huifang, et al.
Publicado: (2021)

Hordenine Protects Against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Inflammation
por: Zhang, Xiyue, et al.
Publicado: (2021)

Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice
Publicado: (1987)

The Anti-inflammatory Mediator Resolvin E1 Protects Mice Against Lipopolysaccharide-Induced Heart Injury
por: Zhang, Jishou, et al.
Publicado: (2020)

Bifidobacterium longum R0175 Protects Rats against d-Galactosamine-Induced Acute Liver Failure
por: Wang, Kaicen, et al.
Publicado: (2020)

Intraperitoneal Administration of Fetuin-A Attenuates d-Galactosamine/Lipopolysaccharide-Induced Liver Failure in Mouse
por: Zhang, Pan, et al.
Publicado: (2014)

Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi‐Organ Failure
por: Uckun, Fatih M., et al.
Publicado: (2020)

Susceptibility of Asialoglycoprotein Receptor-Deficient Mice to LPS/Galactosamine Liver Injury and Protection by Betaine Administration
por: Rasineni, Karuna, et al.
Publicado: (2020)

Protective Effects of Costunolide against Hydrogen Peroxide-Induced Injury in PC12 Cells
por: Cheong, Chong-Un, et al.
Publicado: (2016)

Lysimachiae Herba Inhibits Inflammatory Reactions and Improves Lipopolysaccharide/D-Galactosamine-Induced Hepatic Injury
por: Jeong, Yun Hee, et al.
Publicado: (2021)

BRP, a polysaccharide fraction isolated from Boschniakia rossica, protects against galactosamine and lipopolysaccharide induced hepatic failure in mice
por: Quan, Jishu, et al.
Publicado: (2014)

Levosimendan Increases Survival in a D-Galactosamine and Lipopolysaccharide Rat Model
por: Sakaguchi, Tatsuma, et al.
Publicado: (2022)

Short‐term fasting attenuates lipopolysaccharide/D‐galactosamine‐induced acute liver failure through Sirt1‐autophagy signaling in mice
por: Long, Boyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h7t7dg0d95ok9m1jvulifc5s8i